Article
Hereditary cancer predispositions: Comparison of multigene panel sequencing on fresh-frozen breast/ovarian tumor versus blood.
Clinical genetics - 1 Jul 2023
Schwartz Mathias, Moncoutier Virginie, Peytral Adrien, Le Gall Jessica, Suybeng Voreak, Pagès Mélanie, Masliah-Planchon Julien, Trabelsi-Grati Olfa, Melaabi Samia, Callens Céline, Bièche Ivan, Delhomelle Hélène, De Pauw Antoine, Saule Claire, Mouret-Fourme Emmanuelle, Gauthier-Villars Marion, Buecher Bruno, Colas Chrystelle, Stoppa-Lyonnet Dominique, Golmard Lisa
Abstract excerpt
In breast or ovarian cancer (BC/OC) patients with evocative personal and/or family history, multigene panel sequencing is performed on blood to diagnose hereditary predispositions. Additionally, BRCA1/BRCA2 testing can be performed on tumor sample for therapeutic purpose. The accuracy of multigene panel tumor analysis on BC/OC to detect predisposing germline pathogenic variants (gPV) has not been precisely...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
